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ABSTRACT
The MED1/TRAP220 subunit of the Mediator plays
a key role in facilitating ligand-dependent interac-
tions of this multisubunit coactivator complex with
nuclear receptors through their ligand binding
domains. The isolated MED1/TRAP220 protein pre-
viously was shown to interact with glucocorticoid
receptor (GR) in a ligand-dependent manner.
However, the functional role of MED1/TRAP220,
within the context of the entire Mediator, is not
well studied in GR-mediated transcription. In this
study, we show that GR binds directly to the
Mediator complex and that both LXXLL motifs of
MED1/TRAP220 contribute to its binding to GR.
Furthermore, using a Med1/Trap220
2/2 mouse
embryonic fibroblast (MEF) line that lacks entirely
MED1/TRAP220, we show that MED1/TRAP220
enhances GR-mediated transcription from an
MMTV promoter based-reporter gene and that
mutations in the MED1/TRAP220 LXXLL motifs
reduce, but do not eliminate, GR-dependent tran-
scription. An analysis of endogenous genes in
Med1/Trap220
2/2 cells has confirmed a variable
MED1/TRAP220 requirement for different GR target
genes. Taken together, these findings support the
idea that Mediator, at least in part through MED1/
TRAP220, plays a coregulatory role in ligand-
dependent GR-mediated gene expression.
INTRODUCTION
Nuclear receptors are a large family of transcription
factors that generally regulate transcription in a ligand-
dependent manner. Typical nuclear receptor domains
include a less conserved N-terminal activation domain
(AF1), a highly conserved central DNA-binding domain
(DBD), a hinge region and a conserved C-terminal ligand
binding domain (LBD) that contains activation domain
2 (AF2). Nuclear receptors form homo- or heterodimers
and selectively bind to speciﬁc hormone responsive
elements (HREs) on target gene promoters (1). Receptor
dimers regulate gene expression through recruitment of
various transcription coregulators. These include factors,
such as the p160 family, that directly or indirectly facili-
tate chromatin remodeling, and other factors, such as
Mediator, that act more directly on the general tran-
scription machinery through ligand-independent (AF1
function) and ligand-dependent (AF2 function) mecha-
nisms (2–4).
The Mediator is a well-known nuclear receptor coacti-
vator complex that was ﬁrst identiﬁed in mammalian
cells through intracellular ligand-dependent interactions
with thyroid hormone receptor (TR) and shown to
mediate TR function on DNA templates containing T3
response elements (TREs) in a cell-free system reconsti-
tuted with puriﬁed general transcription factors (5).
Subsequent studies in this and other laboratories identiﬁed
similar or identical complexes and coactivation functions
for a variety of transcription activators (6–11). The
MED1/TRAP220 subunit of Mediator has been impli-
cated in nuclear receptor functions by demonstrations
of (i) ligand-dependent interactions of isolated MED1/
TRAP220 (or derived fragments) with nuclear receptors
(12,13), (ii) stimulatory eﬀects of ectopically expressed
MED1/TRAP220 on nuclear receptor functions (12,13),
(iii) joint ligand- and MED1/TRAP220-dependent inter-
actions of complete Mediator complexes with nuclear
receptors (14–16), (iv) dramatically decreased ability of
Mediator complexes lacking MED1/TRAP220 to coacti-
vate nuclear receptors in vitro (16) and, most convincingly,
(v) compromised nuclear receptor functions in Med1/
Trap220
 /  cells (15,17,18) or in MED1/TRAP220
siRNA-treated cells (19). Consistent with demonstrations
of the role of LXXLL domains in mediating interactions
of a variety of coactivators with nuclear receptors (2),
the LXXLL domains in MED1/TRAP220 have been
shown to be important for ligand-dependent interactions
of isolated MED1/TRAP220 (or derived fragments)
with nuclear receptors (13,20,21), for interactions of
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for optimal nuclear receptor coactivator functions
in vitro (16).
Glucocorticoids, through the action of the glucocorti-
coid receptor (GR), play important roles in regulating
many biological processes that include hematopoiesis,
immune responses and metabolism. Following ligand
binding, dissociation of chaperones, and transport to the
nucleus, dimerized GR binds to glucocorticoid response
element (GRE) sequences in target gene promoters and
positively or negatively regulates gene expression through
recruitment of various transcription coregulators and
chromatin remodeling factors (22–24). Besides studies
implicating p160 family members in GR function (25–27),
a role for the Mediator has also been demonstrated
(28,29). Thus, isolated MED1/TRAP220 and MED14/
TRAP170 proteins were shown to interact with GR
through AF1 and AF2, respectively, and their ectopic
expression was shown to synergistically increase GR-
dependent transcription in transient transfection assays.
Although ectopic MED1/TRAP220 alone failed to
increase GR-mediated transcription (28), this likely
reﬂected the presence of endogenous MED1/TRAP220.
Recent studies using MED14/TRAP170 and MED1/
TRAP220 siRNAs showed that expression of some GR-
target genes was speciﬁcally aﬀected upon reduction of
MED14/TRAP170 or MED1/TRAP220 (29). MED1/
TRAP220 was shown to be recruited to the promoter
of endogenous GR-target genes and to the transfected
MMTV promoter in a ligand-dependent manner (29,30).
These results strongly suggest that MED1/TRAP220 plays
an important role in GR-mediated transcription.
The present study conﬁrms a ligand-dependent inter-
action between GR-LBD and the LXXLL-containing
central domain of MED1/TRAP220 and, importantly,
shows for the ﬁrst time that GR interacts directly with the
complete Mediator complex. It further evaluates contri-
butions of the two MED1/TRAP220 LXXLL domains
both to GR-MED1/TRAP220 interactions and to the
enhancement of GR-dependent transcription by MED1/
TRAP220. In vitro binding assays show that both LXXLL
domains contribute to the interaction between MED1/
TRAP220 and GR, and functional assays with a Med1/
Trap220 null mouse embryonic ﬁbroblast (MEF) cell
line show that MED1/TRAP220, in part through its
LXXLL domains, enhances GR-mediated transcription.
These ﬁndings support our proposal that the Mediator,
through MED1/TRAP220, plays a stimulatory role in
GR-mediated gene expression.
MATERIALS AND METHODS
Plasmid construction
For GST-fusion protein expression, cDNAs were ampli-
ﬁed from corresponding sequences and subcloned into
pGEX vector. A mammalian expression vector for GR
was kindly provided by Dr Kai Ge. cDNAs for MED1/
TRAP220 and mutants were subcloned and expressed
using the pIRESneo vector (Clontech).
Cell culture
HeLa S cells were cultured in suspension in DMEM with
10% bovine calf serum. Wild-type and Med1/Trap220
 / 
MEF cells were cultured in monolayer in DMEM with
10% fetal bovine serum. For preparation of HeLa nuclear
extract under dexamethasone (Dex) conditions, HeLa
S cells were cultured in suspension in DMEM with 10%
charcoal-stripped serum for 24h before harvesting. For
preparation of HeLa nuclear extract under +Dex condi-
tions, HeLa S cells were cultured in suspension in DMEM
with 10% fetal bovine serum and Dex was added to the
culture at a ﬁnal concentration of 10mM 24h before cells
were harvested. To prepare charcoal-stripped serum,
500ml of serum was incubated with 25g of AG1-X resin
(BioRad) at room temperature overnight with stirring.
After the resin was allowed to settle, fresh resin (25g) was
added with 5g of activated charcoal powder and stirred
again at room temperature for 4–6h. The charcoal and
resin were removed by centrifugation and ﬁltration
through a 0.8mm ﬁlter.
Protein purification
GST and GST-fusion proteins were expressed in bacteria
and puriﬁed as described (14). Brieﬂy, the bacterial lysate
was incubated with Glutathione-agarose beads for 4h at
48C. The beads were washed ﬁve times with BC500-0.1%
NP40. The amounts of GST and GST-fusion proteins
on beads were normalized by SDS-PAGE. Mediator was
puriﬁed as described (16).
In vitro proteinbinding assay
The assay was performed with GST-fusion proteins (5mg)
immobilized on glutathione-Sepharose beads (Amersham
Pharmacia) and in vitro-translated
35S-labeled proteins
(TNT kit, Promega). After incubating at 48C for 4h and
washing with buﬀer A (20mM Tris, pH 7.9, 10% glycerol,
0.2mM EDTA, 300mM KCl, 0.5mM DTT, 0.5mM
PMSF, 0.1% NP-40), bound proteins were eluted by
boiling in SDS sample buﬀer, resolved by SDS-PAGE
and visualized by autoradiography.
Transient transfection assay
Wild-type and Med1/Trap220
 /  MEF cells were main-
tained in DMEM with 10% fetal bovine serum. The
MMTV-luciferase reporter contains the MMTV promoter
with GR response elements. Cells were transfected with
the aid of Fugen 6 (Roche) on 24-well plates and total
levels of transfected DNA were kept constant by adjusting
levels of empty vectors. A b-gal plasmid was used as an
internal control for normalizing transfection eﬃciency.
Cells were cultured in DMEM with 10% charcoal-
stripped fetal bovine serum after transfection. One day
after transfection, Dex was added to +Dex wells to a ﬁnal
concentration of 100 nM and luciferase activity was
measured 24h after ligand addition (2 days after
transfection). Luciferase activities are shown as relative
luciferase units (RLU) after normalization by b-gal
activity.
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Figures show the mean and SD of double or triple samples
in representative experiments. Statistical diﬀerences
between treated samples were determined using unpaired
Student’s t-test. P-values are stated in the ﬁgure legends.
Real-time PCR
For preparation of cells for real-time PCR studies, wild-
type and Med1/Trap220
 /  MEFs were seeded in six-well
plates at 10
5 cells/well. The cells were transfected with
0.5mg GR expression vector with the aid of Fugen 6 in
MEM containing charcoal-stripped serum. Two days after
transfection, Dex or vehicle (100% ethanol) was added
to the cells at a ﬁnal concentration of 100nM. Total RNA
was collected 10h after Dex or vehicle treatment using
RNeasy Mini kit (Qiagen). Equal amounts of total
RNA were used for ﬁrst strand cDNA synthesis using
SuperScriptIII First Strand cDNA Synthesis for RT-PCR
kit (Invitrogen) following the manufacturer’s instructions.
Gene expression was analyzed by quantitative real-time
PCR in 25ml reactions using SYBR Green (Applied
Biosystems). 18S RNA was used as an internal control for
normalization. Fold inductions are shown relative to
vehicle-treated control cells. The ﬁgures show mean and
SD of two independent experiments. Primers used in
real-time PCR were: 18S, Forward, 50-AGTCCCTGCCC
TTTGTACACA-30 Reverse, 50-CGATCCGAGGGCCTC
ACTA-30; GILZ, Forward, 50-GGCCCTAGACAACAA
GATTG-30 Reverse, 50-TCAAGCAGCTCACGAATCT
G-30; IRF8, Forward, 50-TCCCAGCTGGACATTTCT
GA-30 Reverse, 50-CCACAGAAGGTTCCTTGATC-30.
RESULTS
GR interacts directly withthe Mediator complex in vitro
To investigate the role of the Mediator in GR-mediated
transcription, we ﬁrst set out to determine whether GR
shows a direct interaction with the complete Mediator
complex. A GST-fusion protein (GST-GR-LBD) contain-
ing the GR ligand binding domain (residues 439–795)
was expressed in bacteria, puriﬁed and immobilized on
glutathione-Sepharose beads. Immobilized GST-GR-LBD
and control GST proteins were incubated with either
HeLa S nuclear extract or with puriﬁed Mediator complex
in the presence of 10mM Dex. After washing, bound
proteins were eluted by boiling in SDS sample buﬀer and
analyzed by immunoblot. This analysis (Figure 1) shows
speciﬁc binding to the GR-LBD of representative
Mediator components (MED1/TRAP220, MED14/
TRAP170, MED17/TRAP80 and MED20/TRFP) both
from HeLa nuclear extract and from the puriﬁed Mediator
preparations. These results demonstrate that the Mediator
complex associates directly with GR through the LBD.
The LXXLL-containing domainof MED1/TRAP220
interacts withthe GR-LBD in aligand-dependent manner
To determine whether MED1/TRAP220 can interact
with GR, GST was fused to a MED1/TRAP220 fragment
(residues 580–701) that contains the two LXXLL domains
(Figure 2B), expressed in and puriﬁed from bacteria
(Figure 2C), and immobilized on GST beads. The
immobilized GST-MED1/TRAP220(580-701) was incu-
bated with in vitro translated,
35S-Met-labeled GR-
AF1-DBD (residues 1–505) or GR-DBD-LBD (residues
439–795) fragments (Figure 2A) in the presence or absence
of Dex and, after washing, bound proteins were eluted and
detected by autoradiography. The analysis in Figure 2D
shows that MED1/TRAP220(580-701) binds strongly to
GR-DBD-LBD in a ligand-dependent manner, but not to
GR-AF1-DBD, thus conﬁrming a similar earlier-reported
result (28). MED1/TRAP220 contains two of the LXXLL
motifs (within NR boxes) typically associated with nuclear
receptor coactivators (Figure 2B, NR1 and NR2). To
determine the relative contributions of these motifs to
MED1/TRAP220 interactions with GR-LBD, mutations
were introduced as shown in Figure 2B (NRa for the
NR1 mutation, NRb for the NR2 mutation and NRab
for the NR1 and NR2 double mutation) and correspond-
ing proteins were expressed and puriﬁed (Figure 2C). As
shown in Figure 3A, GST-MED1/TRAP220NRa and
GST-MED1/TRAP220NRb retain ligand-dependent
interactions with GR-LBD, although the interactions
are signiﬁcantly weaker than for wild-type GST-MED1/
TRAP220NR. Mutation of both NR1 and NR2 com-
pletely abolishes the interaction with GR-LBD. These
results demonstrate that MED1/TRAP220 NR1 and NR2
are both essential for optimal binding of MED1/
TRAP220 to GR and that they contribute equally to
this interaction.
MED1/TRAP220 and GR co-localize inthe nucleus after
ligandtreatment
To further explore the intracellular relationships of GR
and MED1/TRAP220 inside a cell in response to ligand
treatment, cellular localizations of GR and MED1/
TRAP220 were monitored in the absence and presence
of Dex. As shown in Figure 4, and as expected, GR is
predominantly cytoplasmic in HeLa S cells cultured in
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MED14/TRAP170
MED17/TRAP80
I
n
p
u
t
 
N
E
G
S
T
 
C
o
n
t
r
o
l
G
S
T
-
G
R
-
L
B
D
HelaNE
I
n
p
u
t
 
1
0
%
G
S
T
 
C
o
n
t
r
o
l
G
S
T
-
G
R
-
L
B
D
Purified Mediator
MED17/TRAP80
MED1/TRAP220
MED20/TRFP
A B
Figure 1. GR interacts with the Mediator complex. (A) Binding of
Mediator in nuclear extract. (B) Binding of puriﬁed Mediator. Beads
containing bound GST or GST-GR-LBD were incubated with HeLa
nuclear extract (A) or puriﬁed Mediator complex (B) in the presence of
10mM Dex and processed as described in Materials and Methods.
Associated components were identiﬁed by immunoblot with antibodies
(all generated in this lab) to MED1/TRAP220, MED14/TRAP170,
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Nucleic Acids Research, 2007, Vol. 35, No. 18 6163medium with hormone-depleted serum and predominantly
nuclear following treatment with Dex for 24h. In contrast,
MED1/TRAP220 is found exclusively in the nuclear
fraction regardless of Dex treatment. This suggests that,
in vivo, MED1/TRAP220 and GR may interact with
each other only in the presence of ligand due to their
localization in diﬀerent compartments in the absence of
ligand.
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The results of the GST-GR-LBD pull down assay strongly
suggest that the Mediator complex is recruited to GR
target gene promoters through direct interactions between
GR- and Mediator-associated MED1/TRAP220. Thus,
the Mediator could play a functional role in GR-mediated
transcription activation. To test this, Med1/Trap220
 / 
and wild-type MEF cells were transiently transfected
with a GR expression vector and a MMTV-luc reporter.
A b-gal vector was cotransfected in order to monitor
transfection eﬃciency. The activation of MMTV-luc was
measured as relative luciferase units (RLU) after normal-
ization to the b-gal activity. As a control, transfection of
MMTV-Luc alone into Med1/Trap220
 /  and wild-type
MEFs gave only background luciferase activity in the
presence of Dex, indicating that endogenous GR is present
at only a low level and/or inactive in the transfection assay
(Figure 5A, lanes 1 and 6). Cotransfection of GR
increased luciferase activity in a ligand-dependent
manner in both wild-type and Med1/Trap220
 /  MEFs.
However, the induction level in Med1/Trap220
 / 
MEFs was very low compared to the level in wild-
type MEFs (relative luciferase units of 16 and 90 in
Med1/Trap220
 /  and wild-type MEFs, respectively)
(Figure 5A, lane 3 versus lane 7). This indicates that
MED1/TRAP220 plays an important role in enhancing
GR-mediated MMTV-luc activation. To test if the
reduced reporter activity is due to lack of MED1/
TRAP220 in Med1/Trap220
 /  MEFs, these cells were
cotransfected with GR and MED1/TRAP220 expression
vectors. As shown in Figure 5A (lanes 4 and 5) the
MMTV-luc reporter was activated, in a dose-dependent
manner, to a level exceeding that observed in wild-type
cells. Transfection of MED1/TRAP220 alone (Figure 5A,
lane 2) did not activate the reporters, demonstrating that
the activation of MMTV-luc is dependent on transfected
GR. When Med1/Trap220
 /  MEFs were transfected with
a constant amount of a MED1/TRAP220 vector and
increasing amounts of the GR vector, a clear dose-
dependent response to GR was observed (Figure 5B).
These results clearly demonstrate that MED1/TRAP220
enhances GR-mediated transcription activation on the
MMTV-promoter.
Since the NR boxes of MED1/TRAP220 interact with
GR-LBD in a ligand-dependent manner, we next tested
whether the NR boxes are essential for GR-mediated
transcription. To address this question, we introduced
point mutations that changed the LXXLL motif to
LXXAA in the ﬁrst NR box (MED1/TRAP220-a),
in the second NR box (MED1/TRAP220-b) or in
both NR boxes (MED1/TRAP220-ab) (Figure 6B).
Wild-type and mutated MED1/TRAP220 vectors were
cotransfected with MMTV-luc and the GR vector into
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Figure 5. MED1/TRAP220 enhances GR-mediated transcription. (A) MED1/TRAP220 requirement for optimum GR-mediated transcription
activation. Med1/Trap220
 /  and WT MEFs were co-transfected with MMTV-luc reporter (150ng) and vectors expressing GR (25ng) or MED1/
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dosage on MED1/TRAP220 enhanced transcription. Luciferase activities are shown as relative luciferase units (RLU) after normalization by b-gal
activity. Values are the mean and SD of triple (A) or duplicate (B) samples in a representative experiment of at least three.
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Figure 4. MED1/TRAP220 and GR co-localize in the nucleus after
ligand treatment. Nuclear (NE) and cytoplasmic (S100) fractions were
prepared from HeLa S cells grown in the absence or presence of Dex.
MED1/TRAP220 and GR were detected by immunoblot with
corresponding anti-MED1/TRAP220 and anti-GR antibodies.
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 /  MEFs and relative luciferase units were
measured. Compared to the high level of reporter
induction observed with wild-type MED1/TRAP220,
MED1/TRAP220-a and MED1/TRAP220-b showed
slightly (but reproducible) lower levels of induction while
MED1/TRAP220-ab showed an even lower level of
induction (Figure 6A, lane 1 versus lanes 3–6). However,
signiﬁcant activation of MMTV-luc was still observed
with the double mutant (Figure 6A). These results indicate
that, while not essential for a signiﬁcant level of MED1/
TRAP220 enhancement of GR-mediated transcription,
the two NR boxes of MED1/TRAP220 do contribute
to the optimal MED1/TRAP220 enhancement of
GR-mediated transcription activation.
The function of the large ( 800 amino acids) region
of MED1/TRAP220 C-terminal to the LXXLL domain
is poorly characterized. However, recent studies have
shown that this region is phosphorylated by several
kinases (31) and that phosphorylation by the extra-
cellular signal-regulated kinase (ERK) of the mitogen-
activated protein kinase (MAPK) family stabilizes and
increases the intrinsic activity of MED1/TRAP220 (32).
To determine whether the C-terminal domain of MED1/
TRAP220 is required for GR-mediated transcription,
Med1/Trap220
 /  MEFs were cotransfected with GR
and MED1/TRAP220-689 (Figure 6C) expression vectors.
In this assay, MED1/TRAP220-689 enhanced MMTV-luc
activity to a level equivalent to  75% of that observed
with full length MED1/TRAP220 (Figure 6A, lane 8
versus lane 3). This indicates that the C-terminus of
MED1/TRAP220 is also dispensable for a substantial
level of GR-mediated transcription activation. As shown
in Figure 6A (lane 7 versus lane 2), further deletion of
a region (amino acid 531–689) containing two LXXLL
motifs and the surrounding sequences severely reduced the
level of induction. However, point mutations of the two
NR boxes (LXXLL!LXXAA) did not signiﬁcantly aﬀect
the luciferase reporter activation by this N-terminal
fragment (1–670) (Figure 6B). MED1/TRAP220-530,
which contains only the conserved region of MED1/
TRAP220, did not signiﬁcantly enhance the level of
activity seen with GR alone. All these results strongly
suggest that although the two NR boxes contribute to the
optimal MED1/TRAP220 activity, sequences surrounding
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indicated, grown in the presence or absence of Dex as indicated, and processed as described in Materials and Methods. Luciferase activities are
shown as relative luciferase units (RLU) after normalization to b-gal activity. Values are the mean and SD of duplicate samples in a representative
experiment of at least three. Lanes 3-8 were compared with lane 2, lanes 4–8 were compared with lane 3.
  indicates p<0.05,
   indicates p<0.01
with unpaired Student’s t-test. (B) Mutation of the two LXXLL motives does not aﬀect the function of the N-terminal domain of TRAP220 in
enhancing GR-mediated transcription. The experiments were performed and analyzed as described in (A). Lanes 3–5 were compared to lane 2.
  indicates p<0.05. (C) Schematic representation of MED1/TRAP220 and MED1/TRAP220 mutants.
6166 Nucleic Acids Research, 2007, Vol. 35, No. 18the NR boxes play a more important role for MED1/
TRAP220 enhancement of GR-mediated transcription
activation.
In order to examine the role of MED1/TRAP220 in
endogenous GR target gene expression, we analyzed the
expression of GR target genes GILZ and IRF8 in wild-
type and Med1/Trap220
 /  MEFs. Wild-type and Med1/
Trap220
 /  MEFs were transfected with GR vector. Two
days after transfection, Dex or vehicle was added to the
transfected cells at a ﬁnal concentration of 100nM to
induce GILZ and IRF8 expression. RNA was extracted
10h after treatment and real-time PCR was performed
with the RNA. As shown in Figure 7, GILZ and IRF8
were both induced after Dex treatment in wild-type
and Med1/Trap220
 /  MEFs. GILZ was induced equally
well in Med1/Trap220
 /  and wild-type MEFs while the
induction of IRF8 was reduced in Med1/Trap220
 / 
MEFs. These results indicate that TRAP220/MED1
contributes to the IRF8 induction but not to GILZ
induction in response to Dex. These results with MEFs
that are completely devoid of MED1/TRAP220 parallel
those reported by Garabedian and colleagues using
siRNA-mediated knockdown of MED1/TRAP220 (29).
DISCUSSION
Through interactions both with transcriptional activators
and with RNA polymerase II, the Mediator plays a key
role, as a bridging complex, in transmitting signals from
activators, including a broad range of nuclear receptors,
to the general transcription machinery (11). In the case
of nuclear receptors, the MED1/TRAP220 subunit of
Mediator plays a key role in this process through ligand-
dependent interactions with the AF2 domain of many
nuclear receptors. Despite a reported interaction between
GR and the isolated MED1/TRAP220 subunit (28), it has
not been established that GR can interact with the more
physiologically relevant Mediator complex and the role
of the Mediator complex in GR-mediated transcription
has not been well deﬁned.
In this study, we further investigated the functional
role of MED1/TRAP220 in GR-mediated transcription
activation. We ﬁrst showed that a puriﬁed GR-LBD could
bind the intact Mediator complex in a HeLa nuclear
extract. We then demonstrated that the interaction is
direct since the puriﬁed GR-LBD also showed a similarly
strong interaction with a puriﬁed Mediator complex.
Given the reported role of MED1/TRAP220 in facilitating
Mediator recruitment by nuclear receptors, we then
conﬁrmed that MED1/TRAP220 interacts with GR-
LBD in a ligand-dependent manner. These results strongly
suggested that the Mediator complex functions as a GR
coactivator. In support of this hypothesis, Med1/Trap220
null MEFs that are devoid of MED1/TRAP220 showed
a near complete loss of GR-mediated transcription
compared to wild-type MEFs. That this was due directly
to the loss of MED1/TRAP220, rather than an indirect
eﬀect resulting from establishment of the null cell line, was
shown by the ability of an ectopic MED1/TRAP220 to
fully restore GR function in Med1/Trap220 null MEFs
(Figure 5A lanes 4 and 5). Of note, and as shown here for
GR and elsewhere for PPARg and ER (15,19), Med1/
Trap220 null MEFs are useful for establishing cellular
functions of MED1/TRAP220 because the ubiquitous and
abundant expression of MED1/TRAP220 may obscure
visualization of signiﬁcant eﬀects of ectopically MED1/
TRAP220 in common transfection assays. Furthermore,
whereas siRNA-mediated knockdown of MED1/
TRAP220 oﬀers an alternative approach, the presence
of residual levels of MED1/TRAP220 and potential oﬀ
target eﬀects could complicate such analyses.
A role of MED1/TRAP220 in GR-mediated tran-
scription was also studied by Garabedian and colleagues
(28). An initial study showed physical interactions of
GR with two isolated Mediator components, MED14/
TRAP170/DRIP150 and MED1/TRAP220/DRIP205,
whereas transfected reporter assays showed enhancement
of GR function by MED14/TRAP170/DRIP150, but not
by MED1/TRAP220/DRIP205 alone. The later results
likely reﬂected saturating levels of endogenous MED1/
TRAP220 in HeLa cells (Chen,W. and Roeder,R.G.,
unpublished data), a complication avoided in the present
assays. A more recent study from Garabedian and
colleagues (29) showed that siRNA-mediated knockdown
of MED1/TRAP220 reduced the expression of some
GR-target genes such as LAD1 and IRF8 and that
MED1/TRAP220 is recruited to the regulatory region of
GR-target genes (IRF8 and IGFBP1) in a Dex-dependent
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Figure 7. Expression proﬁle of endogenous GR target genes in wild-type and Med1/TRAP220
 /  MEFs. Cells were treated as described in the text,
and real-time PCR was performed as described in Materials and Methods. (A) GILZ is induced to similar levels in wild-type and Med1/TRAP
 / 
MEFs. (B) Induction of IRF8 is reduced in Med1/TRAP220
 /  MEFs relative to wild-type MEFs.
  indicates p<0.05.
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the GR target gene GILZ in response to Dex, siRNA-
mediated knockdown of MED1/TRAP220 had no eﬀect
on GILZ expression (29). That this reﬂects a true MED1/
TRAP220-independent expression of GILZ, and not the
presence of residual MED1/TRAP220, was established
by our demonstration of normal Dex-induced GILZ
expression in Med1/Trap220 null cells. In combination,
the previous (29) and current results strongly implicate
MED1/TRAP220 as an important, albeit gene selective,
coregulator of GR transactivation.
MED1/TRAP220 binding to nuclear receptors involves
interactions of MED1/TRAP220 NR box/LXXLL motifs
with the LBD of nuclear receptors (12,13). We also
demonstrated a role for NR boxes in ligand-dependent
interactions between MED1/TRAP220 and the LBD
of GR. However, in contrast to other studies showing
preferential interactions of other nuclear receptors
with one or other of the two MED1/TRAP220
NR boxes (13,20,21), our analysis indicates that the two
NR boxes contribute equally to MED1/TRAP220 inter-
actions with the GR-LBD and that, whereas individual
NR boxes mediate a low level of binding, both boxes are
required for optimal interactions of MED1/TRAP220 to
the GR-LBD. In functional studies of NR box-mutated
MED1/TRAP220 in Med1/Trap220 null cells, and some-
what surprisingly, it was found, ﬁrst, that single
NR box mutations only slightly reduced MED1/
TRAP220 enhancement of GR function, and second,
that while mutations of both NR boxes eﬀected a greater
reduction of activity, there was still a substantial residual
activity. Similar observations were reported for aryl
hydrocarbon receptor (33) and for the estrogen receptor
(34,38). One possibility is that ectopic reporters, as used
in these analyses, are somewhat permissive because of
relaxed chromatin structure (35,36). Another possibility
is that although the LXXLL motif is important for
optimal MED1/TRAP220/Mediator binding to nuclear
receptors, the sequences surrounding or even distal to
the NR boxes also contribute to GR interactions. In
this regard, ﬂanking sequences have been shown to be
important for MED1/TRAP220 interactions with other
nuclear receptors (20). In the case of the GR coactivator
GRIP1, structure-functional studies have revealed that at
least two GRIP1 components, the LXXLL motif and the
sequences ﬂanking the motif, contribute to the speciﬁc
interactions between GR and GRIP1 (37). On the other
hand, as discussed above, GR also was shown to interact
physically and functionally, through the AF1 domains,
with the MED14/TRAP170/DRIP150, a subunit of
the Mediator complex. Hence, GR may eﬃciently recruit
the Mediator complex through association with
MED14/TRAP170/DRIP150 and MED1/TRAP220/
DRIP205 (28).
In our previous study of the role of MED1/TRAP220
in adipogenesis, we found that the inability of Med1/
Trap220
 /  MEFs to undergo adipogenesis and to fully
express PPARg target genes could be restored by full
length MED1/TRAP220 (15). More recently, we have
found that this deﬁciency can be rescued not only
by the full length MED1/TRAP220, but also by
MED1/TRAP220(1-689), containing the NR box region
but lacking the C-terminus, and, most surprisingly,
by MED1/TRAP220(1-530), lacking both the NR box
region and the C-terminus (Ge,K. and Roeder,R.G.,
unpublished data). These results, along with previous
reports of NR box requirements for optimal nuclear
receptor functions, indicate conditional requirements for
NR boxes for MED1/TRAP220 functions. The present
results, indicating signiﬁcant MED1/TRAP220 enhance-
ment of GR function in the absence of the MED1/
TRAP220 C-terminus and NR boxes, are consistent with
these ﬁndings. Nonetheless, none of these studies eliminate
the possibility that the NR box and C-terminal regions
of MED1/TRAP220 are required for eﬃcient function
of nuclear receptors, including GR, on at least some of
the many nuclear receptor target genes that have been
identiﬁed.
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